Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gene hunt: could sequencing families unlock the roots of mysterious mental illness?

NCT ID NCT07686653

Not yet recruiting Knowledge-focused Sponsor: Centre Hospitalier Universitaire Dijon Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study investigates whether sequencing the genomes of patients with early-onset or unusual psychiatric disorders—along with their biological parents—can uncover hidden genetic causes. Researchers aim to find disease-related gene variants in at least 12% of participants aged 3 to 50 who have atypical features like early onset, treatment resistance, or an unclear diagnosis. If successful, this approach could improve understanding and diagnosis of these complex conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could show that genome sequencing helps diagnose genetic causes for certain psychiatric disorders, potentially guiding more personalized care.
What could go wrong
This is an early-stage study with a modest goal (12% diagnosis rate). It may not find enough genetic links, and results may not apply to all psychiatric conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIAGNOSTIC STRATEGIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

inherited psychiatric disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIAGNOSTIC STRATEGIES GENETIC

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chu Dijon Bourgogne

    Dijon, 21000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.